#373: Creative Clinical Recruitment

Global Medical Device Podcast · 6 Jun 2024 · 49m · Episode 373

What this episode covers

Dr. Kelly Palmer, an Assistant Professor at the University of Arizona and former Principal Investigator at IU School of Medicine, discusses innovative strategies for recruiting diverse populations into clinical trials. She details how moving from traditional mailings to 'guerrilla marketing' and community partnerships with churches and local organizations significantly improved recruitment ROI and trust. Palmer also explains the operational shift from paper-based data collection to electronic data capture (EDC) on iPads to reduce errors and increase efficiency, while emphasizing the need for flexibility in handling logistical barriers like childcare and transportation for participants.

Mentioned

Companies
Greenlight Guru Clinical, IU School of Medicine, University of Arizona, Cathay, American Diabetes Association, Indie Reads, YMCA
Products
iPad
Tools
Electronic Data Capture, Mailchimp

Other shows on the same ground, closest first.

  • Let's Combinate · 47m

    195 - Clinical Trial Design, Oncology Innovation & Decentralized Trials with Archana Sah

    Archana Sah, a clinical development thought leader with 30 years of experience at companies including Genentech/Roche, Bayer, and Medable, explains the rigorous design of oncology clinical trials, emphasizing the shift from placebo to standard-of-care comparators and the critical role of patient diversity. She details the evolution toward Decentralized Clinical Trials (DCTs) and the use of digital health technologies to overcome enrollment barriers and address historical mistrust in medical research. Sah argues that while DCTs introduce complexity for sponsors, they are essential for enrolling diverse populations, provided they are deployed in a 'fit for purpose' manner that balances data integrity with patient burden.

  • Let's Combinate · 8m

    Combi Crumbs: Clinical Trials 101 – From Safety to Strategy

    Archana Sah, a clinical development expert with over 30 years of experience, explains the critical phases of clinical trials for drug approval. She details how Phase 1 focuses on safety and PK/PD measurements, while Phase 2 and 3 assess efficacy in diverse populations, often comparing new drugs against standard-of-care treatments in oncology. Sah emphasizes the importance of protocol design, regulatory alignment with the FDA, and incorporating patient-reported outcomes to capture the patient experience. She also discusses the logistical complexities of patient recruitment, site selection, and the role of various vendors in executing decentralized or hybrid trial models.

  • Let's Combinate · 1h 13m

    038 - "Clinical Trials" with Dan Sfera

    Dan Sfera, founder of Yuma Clinical Trials and author of the Comprehensive Guide to Clinical Research, explains the operational realities of clinical trials, highlighting the conflict between 'patient-centric' technology and actual patient burden. He details the high screen-failure rates in Phase 2 and 3 trials, the critical role of the Investigator's Form 1572, and the specific risks of investigational product mix-ups during randomization. Sfera also discusses the dynamics between sponsors, CROs, and sites, arguing that direct sponsor involvement often yields better outcomes than using rigid CROs.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.